Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134927454> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3134927454 abstract "The goal of this study was to evaluate the benefit of sublesional bevacizumab injection for recurrent respiratory papillomatosis (RRP) as used in a typical clinical practice.A retrospective review of patients with RRP treated between 2011 and 2016 was undertaken. All patients were treated with in-office potassium titanyl phosphate (KTP) laser photoablation. Sublesional bevacizumab injection was used based on joint patient-physician decision making. Papilloma burden was objectively measured on prior recordings by 2 blinded reviewers and described as vocal fold segments affected (VFSA) by papilloma. Each patient served as their own control by comparing times when bevacizumab was or was not used. Mixed model for longitudinal data was used to determine if the previous use of bevacizumab decreased the disease burden.A total of 19 patients met inclusion criteria and all prior laryngoscopic exams were reviewed for VFSA as described above. The mean (SD) number of VFSA when bevacizumab was not used at the prior procedure was 15 (14) as compared to 8 (11) when bevacizumab was used. When adjusted for age, time from initial presentation and baseline disease burden, mixed model showed a decrease of 11 VFSA (95% CI 6.5, 15.5, P < .0001) when bevacizumab was used as compared to when bevacizumab was not used at the prior procedure. In mixed model analysis, there was not a significant association between bevacizumab dose used and VFSA at the subsequent visit (P = .8).Using sublesional bevacizumab intermittently based on clinical findings appears to be effective in improving disease control. Papilloma burden is significantly decreased at the subsequent clinical follow-up following injection of sublesional bevacizumab. The beneficial effect of sublesional bevacizumab may be not be dose-dependent." @default.
- W3134927454 created "2021-03-15" @default.
- W3134927454 creator A5004047564 @default.
- W3134927454 creator A5007286327 @default.
- W3134927454 creator A5030995808 @default.
- W3134927454 creator A5036296432 @default.
- W3134927454 creator A5037276067 @default.
- W3134927454 date "2021-03-01" @default.
- W3134927454 modified "2023-09-26" @default.
- W3134927454 title "Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation of Utility in a Typical Clinical Practice" @default.
- W3134927454 cites W1999245877 @default.
- W3134927454 cites W2029519409 @default.
- W3134927454 cites W2052524201 @default.
- W3134927454 cites W2103128963 @default.
- W3134927454 cites W2142126331 @default.
- W3134927454 cites W2150766933 @default.
- W3134927454 cites W2168611355 @default.
- W3134927454 cites W2319966627 @default.
- W3134927454 cites W2401604009 @default.
- W3134927454 cites W2462872364 @default.
- W3134927454 cites W2725409230 @default.
- W3134927454 cites W2944669628 @default.
- W3134927454 doi "https://doi.org/10.1177/0003489421998215" @default.
- W3134927454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33648353" @default.
- W3134927454 hasPublicationYear "2021" @default.
- W3134927454 type Work @default.
- W3134927454 sameAs 3134927454 @default.
- W3134927454 citedByCount "0" @default.
- W3134927454 crossrefType "journal-article" @default.
- W3134927454 hasAuthorship W3134927454A5004047564 @default.
- W3134927454 hasAuthorship W3134927454A5007286327 @default.
- W3134927454 hasAuthorship W3134927454A5030995808 @default.
- W3134927454 hasAuthorship W3134927454A5036296432 @default.
- W3134927454 hasAuthorship W3134927454A5037276067 @default.
- W3134927454 hasConcept C126322002 @default.
- W3134927454 hasConcept C141071460 @default.
- W3134927454 hasConcept C142724271 @default.
- W3134927454 hasConcept C2776350393 @default.
- W3134927454 hasConcept C2776694085 @default.
- W3134927454 hasConcept C2777802072 @default.
- W3134927454 hasConcept C2779134260 @default.
- W3134927454 hasConcept C2910019179 @default.
- W3134927454 hasConcept C71924100 @default.
- W3134927454 hasConceptScore W3134927454C126322002 @default.
- W3134927454 hasConceptScore W3134927454C141071460 @default.
- W3134927454 hasConceptScore W3134927454C142724271 @default.
- W3134927454 hasConceptScore W3134927454C2776350393 @default.
- W3134927454 hasConceptScore W3134927454C2776694085 @default.
- W3134927454 hasConceptScore W3134927454C2777802072 @default.
- W3134927454 hasConceptScore W3134927454C2779134260 @default.
- W3134927454 hasConceptScore W3134927454C2910019179 @default.
- W3134927454 hasConceptScore W3134927454C71924100 @default.
- W3134927454 hasLocation W31349274541 @default.
- W3134927454 hasLocation W31349274542 @default.
- W3134927454 hasOpenAccess W3134927454 @default.
- W3134927454 hasPrimaryLocation W31349274541 @default.
- W3134927454 hasRelatedWork W14289947 @default.
- W3134927454 hasRelatedWork W16708841 @default.
- W3134927454 hasRelatedWork W18954325 @default.
- W3134927454 hasRelatedWork W20153016 @default.
- W3134927454 hasRelatedWork W3819646 @default.
- W3134927454 hasRelatedWork W5346711 @default.
- W3134927454 hasRelatedWork W5466098 @default.
- W3134927454 hasRelatedWork W61283 @default.
- W3134927454 hasRelatedWork W7623919 @default.
- W3134927454 hasRelatedWork W21140677 @default.
- W3134927454 isParatext "false" @default.
- W3134927454 isRetracted "false" @default.
- W3134927454 magId "3134927454" @default.
- W3134927454 workType "article" @default.